First Eagle Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

First Eagle Investment Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-62,813	Closed	-$1.98M	–	337
2015 Q2	$1.98M	Sell	62,813 -57,099	-48%	-$1.68M	﹤0.01%	202
2015 Q1	$3.52M	Buy	119,912 +20,000	+20%	+$469K	0.01%	190
2014 Q4	$1.85M	Hold	99,912	–	–	﹤0.01%	210
2014 Q3	$1.75M	Hold	99,912	–	–	﹤0.01%	217
2014 Q2	$2M	Sell	99,912 -50,000	-33%	-$965K	﹤0.01%	219
2014 Q1	$2.86M	Sell	149,912 -237,413	-61%	-$4.93M	0.01%	176
2013 Q4	$6.44M	Buy	+387,325	New	+$6.62M	0.02%	159

Other funds holding MRTX

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

First Eagle Investment Management's MRTX Position: Q3 2015 in Review

First Eagle Investment Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2015, closing a stake of 62,813 shares — an estimated $1.98M sold.

First Eagle Investment Management first reported a position in MRTX in Q4 2013 and held it in 7 quarters. The position peaked at $6.44M in Q4 2013. 78 funds tracked by Wall St. Rank hold MRTX as of Q3 2015.

First Eagle Investment Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
First Eagle Investment Management sold 62,813 Mirati Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $1.98M.
First Eagle Investment Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2013 and held it in 7 quarters.
First Eagle Investment Management's Mirati Therapeutics, Inc. Common Stock position peaked at $6.44M in Q4 2013.
78 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2015.

Based on First Eagle Investment Management's 13F filing for Q3 2015, filed 9 Nov 2015.